Logo

Expected Nonrenewals for NHGRI Sequencing Grants Topped Most-Read GenomeWeb News Stories Last Week

Nov 13, 2006
NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Nov. 10.
 
1. NHGRI Expected Not to Renew Agencourt's, Venter's Sequencing Grants (from Nov. 6)
2. In About-Face, Gene Logic Plans to Sell Preclinical Business (from Nov. 9)
3. Large Dutch Genotyping Study to Use Illumina BeadStations, HumanHap550 BeadChips (from Nov. 8)
4. Invitrogen Creates New Sales Position; Ciphergen Names New CFO; Aebersold and Hood New EMBO Members; and Others (from Nov. 10)
5. NIDDK's Genomics Lab Will Now Offer Microarray Services to All of NIH (from Nov. 8)
Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.